Expanding Access to Our Medicines
Expanding Access to Our Medicines
Share
Global Public Health

Expanding Access to Our Medicines

Share
Today's Top Reads Close

Every day, 1,000 young women and girls get HIV, 4,000 lives are lost to TB, and millions who could be helped suffer from serious mental illnesses. Johnson & Johnson's efforts in tackling these health threats, alongside many others, is why the company has continued to rank among the top three working to expand global access to medicines in low- and middle-income countries according to the Access to Medicine Index (ATMI).

This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue